Ikena Oncology Inc. (IKNA)
1.48
-0.03 (-1.99%)
At close: Jan 15, 2025, 11:45 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -68.17M | -68.77M | -34.12M | -44.26M | -16.82M | -40.87M |
| Depreciation & Amortization | 1.02M | 751.00K | 544.00K | 300.00K | 243.00K | 422.00K |
| Stock-Based Compensation | 7.63M | 7.53M | 5.18M | 1.80M | 1.17M | 314.00K |
| Other Working Capital | -18.80M | -14.56M | -33.39M | -8.29M | 64.78M | -544.00K |
| Other Non-Cash Items | 1.44M | 1.52M | 1.17M | 12.10M | -121.00K | 29.02M |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -21.67M | -15.14M | -33.03M | -7.77M | 63.45M | 58.00K |
| Operating Cash Flow | -79.74M | -74.11M | -60.25M | -37.83M | 47.93M | -11.61M |
| Capital Expenditures | -414.00K | -1.43M | -1.76M | -766.00K | -316.00K | -305.00K |
| Acquisitions | n/a | 97.85M | n/a | 3.69M | n/a | 11.27M |
| Purchase of Investments | -90.05M | -216.34M | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 154.61M | 118.48M | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -97.85M | -1.77M | 3.69M | n/a | 11.27M |
| Investing Cash Flow | 64.14M | -99.28M | -1.76M | 2.92M | -316.00K | 10.97M |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | -663.00K | n/a | n/a | -57.00K | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 39.22M | 1.09M | 436.00K | 116.24M | 16.32M | n/a |
| Financial Cash Flow | 75.98M | 1.09M | 131.74M | 116.18M | 16.32M | n/a |
| Net Cash Flow | 60.38M | -172.30M | 69.73M | 81.28M | 63.93M | -639.00K |
| Free Cash Flow | -80.16M | -75.54M | -62.01M | -38.59M | 47.61M | -11.91M |